Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3751_Библиотеки_им_академика_М_И_Перельмана
.pdf
Kawasumi No Yes No 0
a. CookArchBranchdevice(CookMedical,Bloomington,IN):Thisisatwo-branchendograft
designedfordeploymentintozone0.Itismadeofalow-profilewovenpolyestermaterialanda
combinationofnitinolandstainlesssteel,withtwointegralbranchescorrespondingtothe
innominatearteryandtheleftcommoncarotidartery.
44
b. BoltonArchBranchdevice(BoltonMedical,Sunrise,FL):Thedeviceisofferedunder“custom-
made”ordersoutsidetheUnitedStates.ItisbasedontheRelayNBSplatformandmadeofpolyester
fabricandnitinolstentswithoutaproximalbare-springsegment.Branchesareinternalandare
referredastunnels:theseareorientedsothattheanterioronecanbeoptimallyjoinedtotheleft
carotidandtheposterioronetotheinnominateartery.
44
c. MedtronicArchBranchdevice(Medtronic,SantaRosa,CA):Thisdevice,referredtoasMona-
LSA,isasingle-branchdeviceusedforzone2deployments.ItisbasedontheValiantthoracic
endograftplatformandismadeofpolyesterandnitinolmaterial.Inprinciple,thedevicecanbeused
formoreproximalarchzonesaslongasindispensablecoveredvesselscanberevascularized.The
geometryisamodifiedfenestrationwithaninvertedfunnelappearancethatallowstheexternal
segmenttoengagetheoriginofthesubclavianarteryoranyalternatearchvesselandthebridging
stenttoflarewiththewidenedmouthofthefenestration.
44
d. W.L.GoreArchBranchdevice(W.L.GoreMedical,Flagstaff,AZ):Thisdevice,referredtoas
GORETAGthoracicbranchendoprosthesis,isasingle-brancharchdevice,basedonthecTAG
platformandmadeofexpandedpolytethrafluoroethylene(ePTFE)coveringanitinolframe.Itwas
designedfordeploymentinzone0andzone2;however,moreproximalarchzoneswouldrequire
surgicalrevascularizationofindispensablearchbranches.
44
C.InSituFenestration
1. This technique was first described in 2004 by McWilliams and colleagues.
45
This technique is
reserved for zone 1 and zone 2 without the use of extracorporeal perfusion to maintain cerebral
circulationduetoonlytemporarycoverageofthesupra-aorticbranches.
38
2. The basic principle is to allow blood flow to the vital arch branches by fenestrating a thoracic
endograftafterdeployment.
45
3.Initialeffortsinvolvedastiffguidewirefollowedbyaneedleandacuttingballoonangioplasty.Itwas
found later that this technique causes tears in the expanded ePTFE stent graft. Therefore, laser or
radiofrequency puncture has been invoked to create a retrograde in situ fenestration during TEVAR,
followedbyballoonangioplastyanddeploymentofacoveredstent.
38
4. In addition to the fenestration technique, the following fenestrated graft, developed by Kawasumi
LaboratoriesNajuta,hasbeendescribed:
a. TheNajutaendograftsystem(KawasumiLaboratoriesNajuta,Tokyo,Japan):Itisa
fenestratedgraftwithoutbranchesthatwasconstructedwithlongitudinallyconnectedZstents
coveredwithePTFE.
39
D.Physician-ModifiedStentGrafts
1. Custom-made branched and fenestrated endografts can be useful during elective cases but are not
easily applicable during urgent and emergent cases, because of the prolonged manufacturing delay.
Therefore,physicianshaveoptedtomodifyinfrarenalandthoracicdevices“onthebacktable”byadding
https://t.me/med1917

branchesandfenestrations.
2. Devices are usuallycreated with reinforcedfenestrations or branches constructedfrom portionsof
self-expandingstentgrafts.Suchcreativeeffortsmakethesehomemadedevicesanoptionforpatientsin
needofurgentoperation.However,long-termoutcomesarenotknown,placingagreatresponsibilityon
the physician,especiallyif theurgent case is not done under a formal investigationdevice exemption
(IDE)studywithintheUnitedStates.
46
VI.HybridProcedureApproachfortheAorticArch
A.
A. Inanattempttoreducetherisksassociatedwithanopenprocedure,butatthesametimetoavoidthe
limitationsofan endovascular approach,hybridtechniquesare described.Thereare two typesof
hybrid interventions: first,anopen aortic archrepair with distalextensionusing the stentgraftor
frozenelephanttrunkprocedure, and second, anextra-anatomic bypass involvingthe supra-aortic
branchescombinedwithathoracicstentplacementtoallowforaproximalextensionofthelanding
zonesordebranchingprocedure(Fig.5B.6).
FIGURE5B.6 DeploymentofE-vitaopenplusandreconstructionoftheaorticarch.
©JOTECGmbH,afullownedsubsidiaryofCryoLifeInc.
B.FrozenElephantTrunkProcedure
1.TheelephanttrunkprocedurewasfirstdescribedbyBorstandcolleagues
47
in1983totreatextensive
aneurysmaldiseaseoftheentirethoracicaorta.Inthisprocedure,afreeelephantgraftisleftdandlingin
thedescendingaortaforlaterutilizationinthereplacementofthedescendingaortaduringasecondstage.
Katoandcolleagues48reportedthefirstexperiencewithamodificationofthetwo-stagedelephanttrunk
procedure. It consisted in the open surgical approach of the aortic arch with a deployment of an
endovascularstent totreatthe descendingaorta.The originaltechniquehasbeenmodifiedfrom afree
distal anastomosis to a hand-sewnproximal endof thefrozen elephanttrunk toavoid migration. This
techniqueallowsforthemanagementofextensiveaortic aneurysmaldisease withanopenrepairofthe
aortic arch and an antegrade deployment of the thoracic endograft. Additionally, it is used in the
managementoftypeAaorticdissectionstoreduceaneurysmaldegenerationofthedescendingaorta.
38
2.TherearetwoprefabricatedgraftsavailableoutsidetheUnitedStates.
https://t.me/med1917

a. TheE-VitaOpenandtheE-VitaPlus(JOTEC,Hechingen,Germany):Thesedeviceshavethe
longestregistrydatingbackto2005.Theyhavedemonstratedratesofin-hospitalmortalityof16%
foraorticdissectionand13%fornondissections;postoperativestrokeandspinalcordinjuryhave
beenfoundtobe8%and4%,respectively.Withthesedevices,alandingzonelowerthanT10has
beenidentifiedasariskfactorforparaplegia(Fig.5B.7).
38
FIGURE5B.7 TheE-vitaopenplushybridprosthesisanditsdeliverysystem.
©JOTECGmbH,afullownedsubsidiaryofCryoLifeInc.
b. ThoraflexTMHybridPlexusandThoraflexTMHybridAnte-Flo.TerumoAortic(Inchinnan,
UnitedKingdom):Thisdevicehasafour-branch(Plexus)configurationaswellasastraightversion
(Ante-Flo)thatpermittheimplantationoftheaorticarchesindividuallyorasacarrelpatch,
respectively.Ithasreportedratesof7%forperioperativemortalityand7%forspinalinjury.The
ThoraflexTMHybriddevicesiscurrentlyunderinvestigationintheUnitedStatesforaortic
dissection,aneurysmandrupture(Fig.5B.8).
38,49
https://t.me/med1917

FIGURE5B.8 TheThoraflexTMhybridprosthesisanditsdeliverysystem.
©2019TerumoAortic.
C.SurgicalDebranchingProcedure
1. An extra-anatomical bypass from the ascending aorta to the supra-aortic branches using a median
sternotomywasfirstdescribedinthelate1990s.In2000,thefirstextra-anatomicalbypassfromtheleft
commoncarotidtoleftsubclavianassociatedwithaTEVARwasdescribedfortreatmentofanacutetype
Baorticdissection.Debranchingproceduresmaybeperformedwithorwithoutsternotomy.Optionsvary
basedonthelocationofthepathologicprocessalongtheaorticarchzones.
38
2.Thesedebranchingproceduresmaybeperformedinastagedfashionoratthesameoperationtogether
withTEVAR.39Carefulconsiderationisessentialforpatientswithdiseasesaffectingzone0.
38
a. Zone0surgicaldebranching:Zone0deploymentofendograftsisusedwhentheaorticpathology
coverstheascendingaortaandtheproximalaorticarch.Abypassfromtheascendingaortacanbe
usedtocircumventtheoriginsoftheaorticarchbranchesthatarecoveredwiththethoracicstent.If
theoriginoftheinnominatearteryiscompromised,anextra-anatomicbypassformtheascending
aortatotheinnominatearteryisdone.Incaseofneededrevascularizationfortheleftcommon
carotid,anextra-anatomicbypassfortheleftcommoncarotidarteryisconstructedusingthebypass
oftheinnominatearteryasaninflow.Incaseofcoverageoftheleftsubclavianartery,abypasscan
beanastomosedtotheleftcommoncarotidarterygraft.Iftheleftsubclavianarteryisdifficultto
access,itcanbelaterrevascularizedwithsubclaviantranspositionorleftsubclaviantocarotid
arterybypass.Postoperativemortalityhasbeenreportedtobe0%-8%andstrokeratetobe
0%-17%.
38
b. Zone1surgicaldebranching:Zone1debranchingisindicatedforpatientswithdistalaorticarch
pathologythathasaproximallandingzonegreaterthan2cmfromtheinnominateartery.First,an
extrathoracicleftcarotidtorightcarotidbypassisperformedusingan8mmDacrongraft;thiscan
beperformedviatheanteriorsubplatysmalplaneortheretroesophagealroute,thelatterproviding
https://t.me/med1917

theshortestandthemostsecureroutebecauseofthedeeppositionofthegraftintheneck.Also,
somesurgeonspreferthetranspositiontechniqueavoidingtheuseofprostheticmaterial;however,
thatproceduremustbedoneusingasternotomyorhemisternotomy.Inthiscase,atthetimeofbypass
theproximalleftcarotidarteryisligatedtopreventtypeIIendoleak,andtheproximalleft
subclavianisalsoligatedasneeded.Finally,TEVARisperformed.Postoperativemortalityhasbeen
reportedtobe0%-11%andstrokeratetobe11%.
38
c. Zone2surgicaldebranching:Zone2TEVARrequirespreoperativesurgicalrevascularizationof
theleftsubclavianarterytoavoidischemiccomplications.Subclavianrevascularizationis
especiallyimportantinspecificcircumstances.Thesearelistedhere,withthepotentialcomplication
ofnonrevascularizationindicatedinparentheses:whenthereisapatentleftinternalmammarygraft
(immediatemyocardialinfarction),functionalleftupperextremityarteriovenousfistula(fistula
closure),plannedlongsegmentalcoverage(>20cm)ofthedescendingaorta(paraplegia),absentor
atreticrightvertebralartery(posteriorfossastroke),priorinfrarenalaorticoperation(paraplegia),
hypogastricarteryocclusion(various),andthepresenceofaneurysmswhereupcomingintervention
involvingtheaorticarchisanticipated(paraplegia).Usually,azone2debranchingprocedureis
usedfortreatmentoftypeBaorticdissectionandproximaldescendingaorticaneurysms.
Postoperativemortalityhasbeenreportedtobe0%-3.4%andstrokerate3%tobe8.7%.
38
V.Summary
Endovascularmanagementofaorticpathologyhasemergedasaneargoldstandardforthetreatmentofthe
abdominal aorta. The good results from these abdominal interventions have generated enthusiasm for
expanding thetechnology intomore proximalaortic segments. Thedescendingaorta hasbeenthemore
proximalaorticsegmentinwhichmostoftheinteresthasbeenplaced.However,theascendingaortaand
theaorticarchhavebeenapproachedaswell—perhapstheultimatefrontiersforimplementationofthe
endovasculartreatment.
Despite the interest in handling more proximal segments endovascularly, many difficulties arise. The
ascendingaortaisahigh-stakezoneduetotheproximallocationoftheaorticvalveandcoronaryostia
andthedistalpresenceoftheheadvessels.Anymisplacementofathoracicstentcanresultindevastating
consequencessuch as myocardial infarctionor stroke.Finally, the hemodynamic forcesexperiencedin
these segments increase the difficulty for adequate deployment,requiring techniques that decrease the
bloodpressureandthecardiacoutput.
Moreover,theaorticarchrequiresmeticuloussurgicalplanningtobestdecidetheapproachthatwilllimit
theriskofstrokeduetoinstrumentationoftheheadvessels.
Thelackofspecificdevicesfortheascendingaortaandtheinvestigationalnatureofaorticarchdevices
make endovascular management of these segments a new anddeveloping area; such interventions are
largelylimited to high-riskpatients inwhom conventional opensurgeryis notpossible or safe.Thus,
endovascular techniques provide analternative tosole medical management (in nonsurgical patients),
whichwouldbeexpectedtoresultinhighmortalityandmorbidity.
It mustbe remembered that open surgical techniqueshaveachieved previouslyunimaginable levels of
effectiveness and safety. An experienced open surgical opinion should be invoked before pursuit of
excitingbutcomplexendovasculartherapieswithunprovenlarge-scale,long-termresults.
ClinicalPearls
■Aortic aneurysmis a silent disease requiring close monitoring because the first clinical
https://t.me/med1917

manifestationcanbealife-threateningcomplication.
■Aorticdissectionrequiresahighindexofsuspicion,especiallyinpatientswithabruptonset
ofchestorbackpain.
■Theopensurgicalapproachforthemanagementoftheascendingaortaandtheaorticarchis
thegoldstandardfortreatmentofthoracicaorticpathology, withdramaticimprovementsin
safetycomparedwithearliereras.
■Endovascularmanagementoftheascendingaortaandtheaorticarchislargelyreservedfor
high-risksurgicalpatientsinwhomconventionalapproachesareprohibited.
RecommendedReading
38.HiratzkaLF,BakrisGL,BeckmanJA,etal.ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVMguidelinesforthediagnosisand
managementofpatientswiththoracicaorticdisease:executivesummary.Circulation.2010;121:1544-1579.
39.BravermanAC.Diseasesoftheaorta.In:BraunwaldE,MannDL,ZipesDP,LibbyP,BonowR,eds.Braunwald’sHeartDiseasea
TextbookofCardiovascularMedicine.SaundersElsevier;2014.
40.ElefteriadesJA,FarkasEA.Thoracicaorticaneurysmclinicallypertinentcontroversiesanduncertainties.JAmCollCardiol.
2010;55(9):841-857.doi:10.1016/j.jacc.2009.08.08.
41.ElefteriadesJA.Thoracicaorticaneurysm:readingtheenemy’splaybook.CurrProblCardiol.2008;33:203-277.
42.MuettertiesCE,MenonR,WheatleyGHIII.Asystematicreviewofprimaryendovascularrepairoftheascendingaorta.JVascSurg.
2018;67(1):332-342.
43.TanakaA,EstreraA.Endovasculartreatmentoptionsfortheaorticarch.CardiolClin.2017;35(3):357-366.
References
44.ZiganshinBA,ElefteriadesJA.Thoracicaorticdisease.In:StergiopoulosK,BrownDL,eds.Evidence-BasedCardiologyConsult.
London:SpringerLondon;2014:331-353.
45.ErbelR,AboyansV,BoileauC,etal.2014ESCguidelinesonthediagnosisandtreatmentofaorticdiseases:documentcoveringacute
andchronicaorticdiseasesofthethoracicandabdominalaortaoftheadult.Thetaskforceforthediagnosisandtreatmentofaortic
diseasesoftheEuropeanSocietyofCardiology(ESC).EurHeartJ.2014;35(41):2873-2926.
46.PreventionCfDaC.WISQARSLeadingCausesofDeathReports,1999-2015.[cited2017November];Availableat:
http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html.
47.PatelR,PowellJT,SweetingMJ,EpsteinDM,BarrettJK,GreenhalghRM.TheUKEndoVascularAneurysmRepair(EVAR)
randomisedcontrolledtrials:long-termfollow-upandcost-effectivenessanalysis.HealthTechnolAssess.2018;22(5):1-132.
48.LeTB,ParkKM,JeonYS,HongKC,ChoSG.Evaluationofdelayedendoleakcomparedwithearlyendoleakafterendovascular
aneurysmrepair.JVascIntervRadiol.2018;29(2):203-209.
49.LalBK,ZhouW,LiZ,etal.PredictorsandoutcomesofendoleaksintheveteransaffairsOpenVersusEndovascularRepair(OVER)
trialofabdominalaorticaneurysms.JVascSurg.2015;62(6):1394-1404.
50.ShahA,KhoynezhadA.ThoracicendovascularrepairforacutetypeAaorticdissection:operativetechnique.AnnCardiothoracSurg.
2016;5(4):389-396.
51.MuettertiesCE,MenonR,WheatleyGHIII.Asystematicreviewofprimaryendovascularrepairoftheascendingaorta.JVascSurg.
2018;67(1):332-342.
52.GandetT,AlricP,BommartS,CanaudL.Endovascularaorticrepairofachronicascendingandarchaorticaneurysm.JThorac
CardiovascSurg.2017.
53.BaikoussisNG,AntonopoulosCN,PapakonstantinouNA,ArgiriouM,GeroulakosG.Endovascularstentgraftingforascendingaorta
diseases.JVascSurg.2017;66(5):1587-1601.
54.AchneckHE,RizzoJA,TranquilliM,ElefteriadesJA.Safetyofthoracicaorticsurgeryinthepresentera.AnnThoracSurg.
2007;84(4):1180-1185;discussion1185.
55.BinMahmoodSU,VelasquezCA,ZafarMA,etal.Currentsafetyofascendingaorticsurgery.AbstractsoftheAmericanAssociation
ofThoracicSurgeryAorticSymposium,NewYork.2018.
56.HiratzkaLF,BakrisGL,BeckmanJA,etal.2010ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVMguidelinesforthe
diagnosisandmanagementofpatientswiththoracicaorticdisease:areportoftheAmericanCollegeofCardiologyFoundation/American
HeartAssociationTaskForceonPracticeGuidelines,AmericanAssociationforThoracicSurgery,AmericanCollegeofRadiology,
AmericanStrokeAssociation,SocietyofCardiovascularAnesthesiologists,SocietyforCardiovascularAngiographyandInterventions,
https://t.me/med1917

SocietyofInterventionalRadiology,SocietyofThoracicSurgeons,andSocietyforVascularMedicine.Circulation.2010;121(13):e266e369.
57.BravermanAC.Diseasesoftheaorta.In:BraunwaldE,MannDL,ZipesDP,LibbyP,BonowR,eds.Braunwald’sHeartDiseasea
TextbookofCardiovascularMedicine.SaundersElsevier;2014.
58.PetersonMD,DiethrichEB,RudakewichG.AcuteAorticDissection.AorticDiseases:ClinicalDiagnosticImagingAtlas.
Philadeplphia:PA:SaundersElsevier;2009.55-112.
59.NienaberCA,EagleKA.Aorticdissection:newfrontiersindiagnosisandmanagement:PartI:frometiologytodiagnosticstrategies.
Circulation.2003;108(5):628-635.
60.HaganPG,NienaberCA,IsselbacherEM,etal.TheInternationalRegistryofAcuteAorticDissection(IRAD):newinsightsintoanold
disease.JAMA.2000;283(7):897-903.
61.BottaD,ElefteriadesJA,KoulliasG,etal.AcuteAorticDisease.CRCPress;2007.
62.SinhaI,BethiS,CroninP,etal.Abiologicbasisforasymmetricgrowthindescendingthoracicaorticaneurysms:aroleformatrix
metalloproteinase9and2.JVascSurg.2006;43(2):342-348.
63.KoulliasGJ,RavichandranP,KorkolisDP,RimmDL,ElefteriadesJA.Increasedtissuemicroarraymatrixmetalloproteinase
expressionfavorsproteolysisinthoracicaorticaneurysmsanddissections.AnnThoracSurg.2004;78(6):2106-2110;discussion2110-2111.
64.ElefteriadesJA.Thoracicaorticaneurysm:readingtheenemy’splaybook.YaleJBiolMed.2008;81(4):175-186.
65.ElefteriadesJA.Naturalhistoryofthoracicaorticaneurysms:indicationsforsurgery,andsurgicalversusnonsurgicalrisks.AnnThorac
Surg.2002;74(5):S1877-S1880;discussionS1892-S1898.
66.CoadyMA,RizzoJA,GoldsteinLJ,ElefteriadesJA.Naturalhistory,pathogenesis,andetiologyofthoracicaorticaneurysmsand
dissections.CardiolClin.1999;17(4):615-635;vii.
67.CoadyMA,RizzoJA,HammondGL,etal.Whatistheappropriatesizecriterionforresectionofthoracicaorticaneurysms?JThorac
CardiovascSurg.1997;113(3):476-491;discussion489-491.
68.ZafarMA,LiY,RizzoJA,etal.Heightalone(ratherthanbodysurfacearea)sufficesforriskestimationinascendingaorticaneurysm.
JThoracCardiovascSurg.2017.InPress.
69.BrownsteinAJ,ZiganshinBA,KuivaniemiH,BodySC,BaleAE,ElefteriadesJA.Genesassociatedwiththoracicaorticaneurysm
anddissection:anupdateandclinicalimplications.Aorta(Stamford).2017;5(1):11-20.
70.OttoCM.Diseasesofthegreatarteries.In:OttoCM,ed.TextbookofClinicalEchocardiography.6thed.Philadelphia,PA:Elsevier;
2018.446-472.
71.OverviewofAcuteAorticDissectionandOtherAcuteAorticSyndromes[databaseontheInternet].2018.
72.ElefteriadesJA.Thoracicaorticaneurysm:readingtheenemy’splaybook.CurrProblCardiol.2008;33(5):203-277.
73.VelasquezCA,BinMahmoodSU,ZafarMA,etal.Precipitousresolutionoftype-Aintramuralhematomawithmedicalmanagementina
patientwithmetastaticstage4renalcellcarcinoma.IntJAngiol.2017;26(4):267-270.
74.ShultsCC,ChenEP,ThouraniVH,LeshnowerBG.Transapicalthoracicendovascularaorticrepairasabridgetoopenrepairofan
infectedascendingaorticpseudoaneurysm.AnnThoracSurg.2015;100(5):1883-1886.
75.KhoynezhadA,DonayreCE,WalotI,KoopmannMC,KopchokGE,WhiteRA.Feasibilityofendovascularrepairofascendingaortic
pathologiesaspartofanFDA-approvedphysician-sponsoredinvestigationaldeviceexemption.JVascSurg.2016;63(6):1483-1495.
76.KumpatiGS,GrayR,PatelA,BullDA.Endovascularrepairofacuteascendingaorticdisruptionviatherightaxillaryartery.Ann
ThoracSurg.2014;97(2):700-703.
77.OderichGS,PochettinoA,MendesBC,RoederB,PulidoJ,GloviczkiP.Endovascularrepairofsaccularascendingaorticaneurysm
afterorthotopichearttransplantationusinganinvestigationalzenithascendstent-graft.JEndovascTher.2015;22(4):650-654.
78.HortonJD,KolbelT,HaulonS,etal.EndovascularrepairoftypeAaorticdissection:currentexperienceandtechnicalconsiderations.
SeminThoracCardiovascSurg.2016;28(2):312-317.
79.TsilimparisN,DebusES,OderichGS,etal.Internationalexperiencewithendovasculartherapyoftheascendingaortawithadedicated
endograft.JVascSurg.2016;63(6):1476-1482.
80.YangZH,XiaLM,WeiL,WangCS.ComplicationsafterendovascularrepairofStanfordtypeA(ascending)aorticdissection.EurJ
CardiothoracSurg.2012;42(5):894-896.
81.TanakaA,EstreraA.Endovasculartreatmentoptionsfortheaorticarch.CardiolClin.2017;35(3):357-366.
82.RudarakanchanaN,JenkinsMP.Hybridandtotalendovascularrepairoftheaorticarch.BrJSurg.2018;105(4):315-327.
83.MitchellRS,IshimaruS,EhrlichMP,etal.FirstInternationalSummitonThoracicAorticEndografting:roundtableonthoracicaortic
dissectionasanindicationforendografting.JEndovascTher.2002;9(suppl2):II98-II105.
84.FillingerMF,GreenbergRK,McKinseyJF,ChaikofEL,SocietyforVascularSurgeryAdHocCommitteeonTRS.Reporting
standardsforthoracicendovascularaorticrepair(TEVAR).JVascSurg.2010;52(4):1022-1033,1033e15.
85.MoulakakisKG,MylonasSN,DalainasI,etal.Thechimney-grafttechniqueforpreservingsupra-aorticbranches:areview.Ann
CardiothoracSurg.2013;2(3):339-346.
86.LachatM,FrauenfelderT,MayerD,etal.Completeendovascularrenalandvisceralarteryrevascularizationandexclusionofaruptured
typeIVthoracoabdominalaorticaneurysm.JEndovascTher.2010;17(2):216-220.
87.AnthonyLeeW.Statusofbranchedgraftsforthoracicaorticarchendovascularrepair.SeminVascSurg.2016;29(1-2):84-89.
https://t.me/med1917

88.GlorionM,CoscasR,McWilliamsRG,JaverliatI,Goeau-BrissonniereO,CoggiaM.AComprehensivereviewofinsitufenestration
ofaorticendografts.EurJVascEndovascSurg.2016;52(6):787-800.
89.MastracciTM,GreenbergRK.Thoracicandthoracoabdominalaneurysms:branchedandfenestratedendografttreatment.In:
CronenwettJL,JohnstonW,eds.Rutherford’sVascularSurgery.8thed.Elsevier;2014:2149-2168.
90.BorstHG,WalterbuschG,SchapsD.Extensiveaorticreplacementusing“elephanttrunk”prosthesis.ThoracCardiovascSurg.
1983;31(1):37-40.
91.KatoM,OhnishiK,KanekoM,etal.Newgraft-implantingmethodforthoracicaorticaneurysmordissectionwithastentedgraft.
Circulation.1996;94(9suppl):II188-II193.
92.MaWG,ZhengJ,SunLZ,ElefteriadesJA.Openstentedgraftsforfrozenelephanttrunktechnique:technicalaspectsandcurrent
outcomes.Aorta(Stamford).2015;3(4):122-135.
https://t.me/med1917

C H A P T E R 6
EndovascularRepairoftheDescendingAorta
AymanSaeyeldinMD
YoungErbenMD
MohammadA.ZafarMD
AfshaAurshinaMBBS
CamiloA.VelasquezMD
Wei-GuoMaMD
ChandniPatelMD
JeremyD.AsnesMD
BulatZiganshinMD,PhD
JohnA.ElefteriadesMDPhD(hon),andBauerE.Sumpio,MD,PhD
I.Introduction
II.AnatomicBackground
A.LandingZones
B.SpinalPerfusion
III.IndicationsforTEVAR
A.ThoracicAorticAneurysms
B.ThoracicAorticDissection
C.OtherPathologies
IV.EndograftStructure
A.DeliverySystem
B.MainDevice
C.Extensions
V.AvailableEndograftsforTEVAR
A.TAGandCTAG
B.ZenithTX2andZenithAlpha
C.ValiantThoracicStent-GraftSystem
D.Relay
VI.InvestigationalDevices
https://t.me/med1917

A.TAArget
B.E-Vita
C.StreamlinerMultilayerFlowModulator
VII.PreproceduralPlanning
A.Imaging
B.LandingZones
C.ChoosingtheCorrectGraft
D.DebranchingProcedures
E.OtherApproaches
VIII.PreoperativePreparation
A.Antibiotics
B.RenalInjury
C.CerebrospinalFluidDrainage
IX.TechniqueofPlacement
A.AccessVessels
B.Deployment
C.EvaluatingforEndoleaks
D.PostoperativeImaging
X.Complications
A.PerioperativeMortalityandMorbidity
B.Endoleaks
C.SpinalCordIschemia
D.Stroke
E.Ischemia
F.AccessComplications
G.PostimplantationSyndrome
XI.LateComplications
A.SurvivalandOutcomes
B.MigrationoftheGraft
C.SecondaryIntervention
XII.Conclusion
KeyPoints
■TEVARisasafeandeffectivemethodfortreatmentofvariouspathologiesaffectingthe
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
